{"title":"Prostate Specific Antigen (PSA) testing in a general practice 2009-2019.","authors":"Niall Maguire, Andrea Moloney, Krzysztof Fic","doi":"10.1007/s11845-024-03804-4","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Prostate-specific antigen (PSA) testing is not recommended as a population screening measure for prostate cancer. PSA testing is nevertheless widespread and is associated with harm due to false-positive test results, overdiagnosis and economic costs.</p><p><strong>Aims: </strong>This study sought to document the exposure of patients to PSA testing over a decade in a general medical practice setting.</p><p><strong>Methods: </strong>Laboratory results for each year were extracted from the clinical record. A chart review was undertaken for cases of prostate cancer.</p><p><strong>Results: </strong>We report 13,743 PSA results in 3313 men. In any year, 18% of all men and 33% of men aged over 50 years had at least one PSA test. Between 4.8 and 21% of first tests exceeded age normal values depending on age. There were 113 incident cancers in the study interval of which 84 (74%) were screen detected. Mortality was lower in screen-detected than symptomatic cancers.</p><p><strong>Conclusions: </strong>Men at our practice are significantly exposed to PSA testing. We found evidence of possible overdiagnosis.</p>","PeriodicalId":14507,"journal":{"name":"Irish Journal of Medical Science","volume":" ","pages":""},"PeriodicalIF":1.7000,"publicationDate":"2024-10-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Irish Journal of Medical Science","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s11845-024-03804-4","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"MEDICINE, GENERAL & INTERNAL","Score":null,"Total":0}
引用次数: 0
Abstract
Background: Prostate-specific antigen (PSA) testing is not recommended as a population screening measure for prostate cancer. PSA testing is nevertheless widespread and is associated with harm due to false-positive test results, overdiagnosis and economic costs.
Aims: This study sought to document the exposure of patients to PSA testing over a decade in a general medical practice setting.
Methods: Laboratory results for each year were extracted from the clinical record. A chart review was undertaken for cases of prostate cancer.
Results: We report 13,743 PSA results in 3313 men. In any year, 18% of all men and 33% of men aged over 50 years had at least one PSA test. Between 4.8 and 21% of first tests exceeded age normal values depending on age. There were 113 incident cancers in the study interval of which 84 (74%) were screen detected. Mortality was lower in screen-detected than symptomatic cancers.
Conclusions: Men at our practice are significantly exposed to PSA testing. We found evidence of possible overdiagnosis.
期刊介绍:
The Irish Journal of Medical Science is the official organ of the Royal Academy of Medicine in Ireland. Established in 1832, this quarterly journal is a contribution to medical science and an ideal forum for the younger medical/scientific professional to enter world literature and an ideal launching platform now, as in the past, for many a young research worker.
The primary role of both the Academy and IJMS is that of providing a forum for the exchange of scientific information and to promote academic discussion, so essential to scientific progress.